Current Topics in Healthcare 2024
September 18-20, 2024
Westgate Las Vegas Resort & Casino
More ...
View sample from Sept 19 2024
About This Course
his on demand course was recorded live in Westgate Resort and Casino where Las Vegason September 18-20 2024. It provides 15 hours. live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.
Price $299
-
1. Review recent updates to the standards of care recommended by the American Diabetes Association.
2. Describe recent clinical evidence for new diabetes medications and their implications for patient care.
3. Evaluate the use of wearable devices (automated insulin delivery systems and continuous glucose monitors) in the management of diabetes.
4. Formulate comprehensive management strategies for type 2 diabetes using guideline recommendations, patient characteristics, and glucose data.
-
1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, and heart failure.
2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease.
3. Identify how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator.
4. Discuss a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement.
5. List guideline recommendations supporting the use of antiplatelet therapy for primary prevention patients.
6. Summarize the evidence-based CV risk reduction benefits of medications used to treat overweight and obese patients.
7. Describe the pillars of therapy for heart failure.
8. Review results from cardiovascular outcome trials evaluating the use of angiotensin–neprilysin inhibition in heart failure with reduced ejection fraction.
-
1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypercholesterolemia, chronic coronary disease, peripheral arterial disease, and atrial fibrillation.
2. Identify the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia.
3. List recommendations from the ACC Expert Consensus Decision Pathway for nonstatins and treatment of hypertriglyceridemia.
4. Describe the evidence and guideline recommendations supporting the use of antiplatelet and antithrombotic therapy for secondary prevention patients.
5. List evidence-based drug therapy recommendations for the management of patients with chronic coronary disease and peripheral arterial disease.
6. Recognize the role of colchicine in the prevention of CV events.
7. Discuss pharmacotherapy used for reducing the risk of stroke and rate and rhythm control in atrial fibrillation.
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
Dr. Jennifer M. Trujillo, PharmD, BCPS, CDE, BC-ADM
Clinical Interests
Dr. Trujillo practices at The University of Colorado Center for Adult Diabetes Care and Research. The center's inter-professional team provides diabetes management and education to patients with both type 1 and type 2 diabetes. Clinical research areas of interest include inpatient and outpatient diabetes management and education. Dr. Trujillo also engages in educational research and the scholarship of teaching and learning, curricular development and assessment
Conference Credit
PHARMACISTS : University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .
PHYSICIANS: This CME program offers Category 2 credit.
PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval
“The speaker was extremely knowledgeable and presented the material in a logical way that made it so easy to absorb. Some content was very complex, but due to the speaker high level of skill , he made it so understandable and easy to retain Thanks so much
The speaker provided a great knowlege of historical studies and future studies regarding new agents for treatment of hyperlipdemia and prevention of CCD.
”
“This course was very helpful in Formulating comprehensive management strategies for type 2 diabetes using guideline recommendations. the speaker was very knowledgeable
I thought the speaker was very knowledgable and versed in the new guidelines for management of DM with SGPLT2 and GLP-1.
For someone who has not worked closely in this space in a few years, the speaker was able to convey information in a digestible manner for all skill set levels. Very pleased with class.”
“I definitely picked up some pearls from this speaker as he went over lifestyle modifications for HTN including drink equivalents that are very important. I appreciate his extent of knowledge.
I really appreciated the case studies he shared, especially comparing a 33 yo patient to a 58 yo patient with the same health profile.
I am RN, the class makes me thinking more when interviewed patients! Thanks
”